Taken together, our results show that we have identified the YB-1/CCT4/mLST8/mTOR axis as a contributor to glioblastoma growth and suggest a therapeutic approach to target this axis using competitive RNA oligonucleotides. Here, CCT4 is linked to glioblastoma.